恒瑞医药(600276.SH)子公司SHR-3821注射液等药物获批开展临床试验
Last Update:
13 5 月, 2026
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.